ALISSA GRACY: Open Payments
NPI 1295201408 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 8 payments from 7 companies in 2025. Trend: 2023 $417 · 2024 $729 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $187 |
| Ipsen Biopharmaceuticals, Inc | 1 | $125 |
| Ardelyx, Inc. | 1 | $124 |
| ABBVIE INC. | 1 | $122 |
| Intercept Pharmaceuticals, Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $56 |
| Organon LLC | 1 | $19 |
Products named: IQIRVO, IBSRELA, RINVOQ, OCALIVA, Livdelzi, Epclusa, ENTYVIO, HADLIMA.
Industry payments across MI — which companies pay providers there.
